Patent 7803904 was granted and assigned to Millennium Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.
The present invention relates to fusion proteins comprising a naturally occurring primate MAdCAM, wherein said naturally occurring primate MAdCAM binds α4β7 integrin and has at least about 75% amino acid similarity to an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6.